Puma reports judge invalidated Tagrisso patents; Wyeth appeals Sept 12

PUMA BIOTECHNOLOGY, INC.

Jury awarded $107.5M for past infringement of '314 and '162 patents through Dec 2023.
Judge granted AstraZeneca's motion, ruling patents invalid for lack of enablement/written description.
Wyeth filed notice of appeal on Sept 12, 2024, challenging the invalidity ruling and other adverse orders.
Puma was dismissed as plaintiff but retains contractual rights to recover damages under Pfizer agreement.
Puma respectfully disagrees with the invalidity ruling; post-trial motions for supplemental damages and ongoing royalties pending.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.